Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MMS22L (MMS22 like, DNA repair protein) encodes a DNA repair protein that forms a critical complex with TONSL (tonsoku-like, DNA repair protein), known as the MMS22L-TONSL complex. This complex functions as a genome caretaker and promotes homologous recombination-mediated repair of DNA double-strand breaks and stalled or collapsed replication forks, primarily by facilitating loading and assembly of the RAD51 recombinase on single-stranded DNA. MMS22L is essential for protecting DNA during the replication process and maintaining genome integrity, interacting with RPA-coated ssDNA, RAD51, and potentially NFKBIL2 for chromatin regulation. MMS22L is overexpressed in various cancers, underscoring its importance for rapidly dividing tumor cells and identifying it as a promising target for cancer therapy and chemical sensitization. Loss of MMS22L leads to increased endogenous DNA double-strand breaks and heightened sensitivity to DNA replication stress-inducing agents such as camptothecin. No direct small-molecule inhibitors or approved drugs currently target MMS22L directly; its role is primarily elucidated via genetic depletion or inhibition studies. It is not a receptor, enzyme, ion channel, transporter, or transcription factor, but instead acts as a DNA repair regulator—a chromatin-associated DNA repair facilitator.
Drugs like camptothecin cause replication fork stalling/collapse; MMS22L-TONSL functions to repair these lesions via homologous recombination
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MMS22 like, DNA repair protein (MMS22L).